Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast-track multimodal cardiac anesthesia for elective CABG
ACTRN12625001245482Phase 4Completed
- Sponsor
- Austin Health
- Start
- Nov 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methadone, dexmedetomidine, ketamine, lidocaine and magnesium in coronary arteriosclerosis (2 arms), sponsored by Austin Health. Primary endpoint: Feasibility composite endpoint. Started Nov 2025; status: completed.
02
Drugs
methadonedexmedetomidineketaminelidocainemagnesium
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12625001245482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001245482.